期刊文献+

脆性组氨酸三联体和Ki67蛋白在卵巢上皮性肿瘤组织中的表达及其临床意义 被引量:2

Study on expression and clinical significance of FHIT and Ki67 protein in primary epithelial ovarian tumor
暂未订购
导出
摘要 目的:探讨脆性组氨酸三联体(fragile histidine triad,FHIT)和Ki67蛋白在卵巢上皮性肿瘤组织中的表达及临床意义。方法:采用免疫组化方法检测40例卵巢原发性上皮性癌、20例卵巢交界性肿瘤和20例卵巢良性腺瘤组织中FHIT和Ki67蛋白的表达。结果:卵巢上皮性癌中FHIT蛋白阳性率为65%(26/40),明显低于交界性肿瘤95%(19/20)和良性肿瘤100%(20/20),P值分别为0·012和0·002;而Ki67蛋白阳性率为65%(26/40),明显高于交界性肿瘤0(0/20)、良性肿瘤0(0/20),P值均为0·000。卵巢癌中浆液性癌FHIT蛋白表达率低于非浆液性癌(P=0.000),FHIT蛋白表达率与细胞分化程度(P=0·007)、FIGO分期(P=0·048)及淋巴结转移(P=0·018)相关,与术后残留灶大小(P=0·347)无关。卵巢癌中Ki67蛋白表达率与FIGO分期(P=0·007)、细胞分化程度(P=0·048)及淋巴结转移情况(P=0·041)相关,与病理类型(P=0·273)及残留灶大小(P=0·219)无关。卵巢癌中FHIT蛋白表达与Ki67蛋白的表达呈负相关,rs=-0·543,P=0·015。结论:FHIT基因表达下降,可能与卵巢癌发生和发展有关;联合检测FHIT和Ki67表达情况可能有助于判断卵巢癌患者的预后。 OBJECTIVE: To investigate the expressions and correlation of fragile histidine triad and Ki67 protein in primary epithelial ovarian tumor. METHODS:Expressions of FHIT and Ki67 proteins in primary ovarian epithelial tumors(malignant n = 40, borderline tuner n = 20, benign adenoma n = 20) were evaluated by the immunohistochemical stain. RESULTS: Expression of FHIT protein in primary epithelial ovarian cancers (65%, 26/40) was significantly lower than that in ovarian borderline turnors(95%, 19/20), P = 0. 012, and ovarian benign adenoma (100%, 20/20), P= 0. 002. Ki67 protein was detected positive in 65% (26/40) of the epithelial ovarian cancers,which was significantly higher than that in ovarian borderline tumor (0, 0/20), and ovarian benign adenoma(0,0/20), P=0. 000. Expression of FHIT protein in ovarian serous cancer was significantly lower than that in non-serous ones, P=0. 000. Expression of FHIT protein was significantly correlated with the differentiated grade (P=0. 007), FIGO stage (P=0. 048) and lymph node metastasis, P= 0. 018. But was not correlated with the diameter of residual tumors, P= 0. 347. The present data demonstrated that the expression of Ki67 protein in epithelial ovarian cancer was significantly correlated with FIGO stage (P= 0. 007), the differentiated ( P = 0. 048) and lymph node metastasis (P=0. 041), but was not correlated with different histological classifications (P=0. 273)and the volume of residual tumors, P=0. 219. A significantly inverted relationship was observed between FHIT and Ki67 protein expressions in primary epithelial ovarian cancers (Spearman rank coefficience,r=-0. 543, P=0. 015). CONCLUSIONS: Decreasement of FHIT protein expression may be correlated with carcinogenesis and evolution of the epithelial ovarian cancer. The combinatory detection of FHIT and Ki67 protein expression may be helpful to decem the poorer prognostic patients.
出处 《中华肿瘤防治杂志》 CAS 2006年第9期669-672,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 卵巢肿瘤/病理学 组氨酸/遗传学 基因 肿瘤抑制 免疫组织化学 ovarian neoplasms/pathology histidine/genetics, gene, tumor suppressor immunohistochemistry
  • 相关文献

参考文献18

  • 1Ozols R F.Progress in ovarian cancer:an overview and perspective[J].EJC Supplements,2003,1(2):43-55.
  • 2Fujishita T,Doi Y,Sonoshita M,et al.Development of spontaneous tumours and intestinal lesions in Fhit gene knockout mice[J].Br J Cancer,2004,91(8):1571-1574.
  • 3Sard L,Accornero P,Tornielli S,et al.The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control[J].Proc Natl Acad Sci U S A,1999,96(15):8489-8492.
  • 4Ozaki K,Enomoto T,Yoshino K,et al.Impaired FHIT expression characterizes serous ovarian carcinoma[J].Br J Cancer,2001,85(2):247-254.
  • 5Concin N,Hefler L,van Bavel J,et al.Biological markers in pT1 and pT2 ovarian cancer with lymph node metastases[J].Gynecol Oncol,2003,89(1):9-15.
  • 6Ohta M,Inoue H,Cotticelli M G,et al.The FHIT gene,spanning the chromo-some 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint,is abnormal in digestive tract cancers[J].Cell,1996,84(4):587-597.
  • 7Brenner C,Bieganowski P,Pace H C,et al.The histidine triad supperfamily of nucleotide-binding proteins[J].Cellular Phys,1999,181 (2):179-187.
  • 8Chaudhuri A R,Khan L A,Prasad V,et al.The tumor suppressor protein FHIT:a novel interaction with tubulin[J].Biol Chem,1999,274 (34):24378-24382.
  • 9Ishii H,Dumon K R,Vecchione A,et al.Potential cancer therapy with the fragile histidine triad gene:review of the preclinical studies[J].JAMA,2001,286(19):2441-2449.
  • 10Mandai M,Konishi I,Kuroda H,et al.Expression of abnormal transcripts of the FHIT (fragile histidine triad) gene in ovarian carcinoma[J].Eur J Cancer,1998,34(5):745-749.

二级参考文献14

  • 1钱洪流,宗永生,张昌卿.鼻咽癌中p53蛋白积聚的生物学特征和临床意义[J].临床与实验病理学杂志,1996,12(1):15-18. 被引量:20
  • 2[1]Buttitta F, Marchetti A, Radi O, et al. Evaluation of FHIT gene alterations in ovarian cancer[ J]. Br J Cancer, 1998,77:1048-1051
  • 3[2]Launonen V,Mannermaa A, Stenback F, et al. Loss of heterozygosity at chromosomes 3,6,8, 11,16, and 17 in ovarian cancer: correlation to clinicopathological variables[ J]. Cancer Genet Cytogenet,2000,122:49-54
  • 4[3]Zhang GL, Xu KL. Loss of heterozygosity at chromosomes 3 in epithelial ovarian cancer in China[J].Inter J Gynecol Cancer, 2002,12:198-201
  • 5[4]Ohta M,Inoue H, Cotticelli MG,et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinomaassociated t(3:8) breakpoint, is a abnormal in digestive tract cancers[J]. Cell, 1996,84:587-597
  • 6[5]Mandai M, Konishi I, Kuroda H, et al. Expression of abnormal transcripts of the FHIT(fragile histidine triad) gene in ovarian cancinoma [ J ]. Eur J Cancer, 1998,34: 745- 749
  • 7[6]Ozaki K, Enomoto T, Yoshino K, et al. Impaired FH-IT expression characterizes serous ovarian carcinoma[ J]. Br J Cancer,2001,85:247-254
  • 8[7]Campiglio M, Pekarsky Y, Menard S, et al. FHIT loss of function in human primary breast cancer correlates with advanced stage of disease[J]. Cancer Res, 1999,59:3866-3869
  • 9[8]Hao XP, Willis JE, Pretlow TG, et al. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions[ J]. Cancer Res,2000,60:18-21
  • 10[9]Chaudhuri AR, Khan IA, Prasad V, et al. The tumor suppressor protein FHIT. A novel interaction with tubulin[J].J Biol Chem, 1999,274: 24378-24382

共引文献9

同被引文献24

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部